C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
12/2011
12/28/2011	EP2398777A1 Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
12/28/2011	EP1922307B1 Heterocyclic inhibitors of mek and methods of use thereof
12/28/2011	CN102295606A 合成3-（1，3-苯并间二氧杂环戊烯-5-基）-6-（4-环丙基哌嗪-1-基）-哒嗪的方法及其适用的中间体 Synthesis of 3- (1,3-benzodioxol-5-yl) -6- (4-cyclopropyl-piperazin-1-yl) - pyridazine method and suitable intermediates
12/28/2011	CN101205202B 取代苯基脲类化合物及其制备与应用 Substituted compounds and their preparation and application Phenylurea
12/22/2011	US20110313000 Ccr9 inhibitors and methods of use thereof
12/21/2011	CN101486683B 哒嗪酮和三嗪酮化合物及其作为药物制剂的用途 Pyridazinone and triazinone compounds and their use as pharmaceutical preparations
12/20/2011	US8080551 HIV inhibiting pyrimidines derivatives
12/15/2011	WO2011154677A1 Substituted n-[1-cyano-2-(phenyl)ethyl] 1-aminocycloalk-1-ylcarboxamide compounds - 760
12/15/2011	WO2011097649A3 Methods and apparatus for synthesizing imaging agents, and intermediates thereof
12/14/2011	EP2393361A1 Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
12/14/2011	CN102276535A 芳嗪巯乙酰胺类衍生物及其制备方法与应用 Piperazine derivatives of aromatic thiol Acetamides its preparation method and application
12/13/2011	US8076331 Substituted pyridazine derivatives
12/06/2011	CA2504160C Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
12/01/2011	US20110294818 1h-quinazoline-2,4-diones
11/2011
11/30/2011	EP2389371A2 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
11/30/2011	EP2389364A2 New method for obtaining 5-amino-2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine
11/29/2011	US8067590 Melanin-concentrating hormone (MCH) receptor antagonists; treating obesity, eating disorders, affective disorders, drug dependency; compounds are amino-functional pyridazin-3-one, 1H-pyridin-2-one or 3H-pyrimidin-4-one
11/29/2011	US8067589 Heterocyclic compounds useful in treating diseases and conditions
11/24/2011	WO2011145669A1 Amide derivative
11/24/2011	US20110288296 Production and use of zinc amides
11/24/2011	US20110288092 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
11/23/2011	CN102256968A Heterocyclic antiviral compounds
11/23/2011	CN102256944A Sphingosine-1-phosphate receptor antagonists
11/23/2011	CN102250014A Method for preparing chiral 1-benzyloxycarbonyl hexahydropyridazine-3-carboxylic acid and chiral 1, 2-dibenzyloxycarbonyl hexahydropyridazine-3-carboxylic acid
11/22/2011	US8063070 Bicyclic benzamides of 3-or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/22/2011	US8063049 Inhibitors of MEK
11/22/2011	US8063047 Pyridazine compounds and methods
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281876 Therapeutic agents useful for treating pain
11/16/2011	EP2386554A1 Compounds active at the histamine H3 receptor
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	CN101484428B Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-HSD 1)
11/15/2011	US8058429 Diazaphosphacycle transition metal complexes
11/10/2011	US20110275792 Metal coordinated compositions
11/10/2011	US20110275642 New method for obtaining 5-amino 2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine
11/10/2011	US20110275641 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/09/2011	EP1651620B1 Piperazine derivatives and their use as therapeutic agents
11/08/2011	CA2618393C Bis-aryl amide compounds and methods of use
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269722 Prodrugs containing novel bio-cleavable linkers
11/02/2011	EP2383259A1 New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
11/02/2011	EP2383258A1 Method for rapidly methylating heteroaromatic ring aryl and method for producing pet tracer
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/2011
10/27/2011	WO2011133444A1 Substituted pyrimidines
10/27/2011	US20110263849 Method for rapidly methylating heteroaromatic arene and method for producing tracer for use in pet
10/27/2011	US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011	US20110263530 Aurora Kinase Modulators and Method of Use
10/26/2011	EP2380885A1 Guanidine compounds and use of same as binding partners for 5-HT5 receptors
10/26/2011	EP2379534A1 Heterocyclic antiviral compounds
10/26/2011	EP2379509A1 Phenyl-substituted pyridazinone acting as herbicide and insecticide
10/26/2011	EP2379508A1 Herbicidally and insecticidally effective 4-phenyl-substitued pyridazinones
10/25/2011	US8044242 2-(aryloxy) acetamide factor VIIa inhibitors useful as anticoagulants
10/25/2011	US8044198 Sirtuin modulating compounds
10/25/2011	US8044053 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
10/25/2011	US8044041 Phthalazine derivatives as inhibitors of protein kinase
10/20/2011	WO2011130661A1 Methods of using dihydropyridophthalazinone inhibitors of poly (adp-ribose)polymerase (parp)
10/19/2011	EP2004607B1 (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-N-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof
10/19/2011	EP1851210B1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
10/19/2011	CN102224217A Electroluminescent device using the electroluminescent compounds
10/18/2011	US8039472 Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
10/13/2011	US20110251208 Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
10/13/2011	US20110251068 Parasitic plant control agent and parasitic plant control method
10/13/2011	US20110250145 Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
10/12/2011	EP2374800A2 Methods for the preparation of 4-[3-(4-cyclopropanecarbonyl- piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
10/12/2011	EP2064189B1 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/05/2011	EP2370413A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/05/2011	EP1960370B1 Pyridiazinone derivatives for tumour treatment
10/05/2011	EP1648874B1 Piperazine derivatives and their use as therapeutic agents
10/05/2011	CN101817788B Preparation method of 3,4,6-trichloro-pyridazine
10/04/2011	US8030517 CCR9 inhibitors and methods of use thereof
10/04/2011	US8030488 Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents
10/04/2011	CA2599403C Phthalazine, aza- and diaza-phthalazine compounds and methods of use
10/04/2011	CA2510528C Biphenyl derivatives and their use as fungicides
10/04/2011	CA2491079C Therapeutic piperazine derivatives useful for treating pain
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
09/2011
09/29/2011	WO2011118672A1 Plasma kallikrein inhibitor
09/29/2011	US20110237595 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
09/29/2011	US20110237589 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/29/2011	US20110237571 Phthalazine derivatives
09/28/2011	CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/27/2011	US8026240 Octahydro-pyrrolo[3,4-b]pyrrole N-oxides
09/27/2011	CA2457410C Compounds effecting glucokinase
09/22/2011	US20110229941 Novel Gene Cluster
09/21/2011	EP2366697A1 Guanidine compounds and use of same as binding partners for 5-HT5 receptors
09/21/2011	EP2366392A1 Guanidine compounds and use of same as binding partners for 5-HT5 receptors
09/20/2011	CA2597069C Pyridazine derivatives and their use as therapeutic agents
09/20/2011	CA2510534C Compositions useful as inhibitors of protein kinases
09/15/2011	US20110224433 Process for Manufacturing Substituted 3-pyridylmethyl Ammonium Bromides
09/15/2011	US20110224244 Adamantyl Benzamide Derivatives
09/15/2011	US20110223093 Ionic liquid systems for carbon dioxide and sulfur dioxide removal
09/14/2011	EP2364973A1 Heterocyclic inhibitors of MEK and Methods of use thereof
09/14/2011	EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof
09/09/2011	WO2011107295A1 Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms
09/09/2011	CA2791327A1 Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms
09/07/2011	EP2363399A1 Labelled analogues of halobenzamides as radiopharmaceuticals

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 85